Results 121 to 130 of about 11,673 (224)

17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth? [PDF]

Am J Obstet Gynecol MFM, 2021
Hynes JS, Schwartz AR, Abdalla A, Manuck TA, Dotters-Katz SK.   +4 more
europepmc   +1 more source

Salivary 17-hydroxyprogesterone (17-OHP) and androstenedione in monitoring efficacy of treatment among Indonesian Congenital Adrenal Hyperplasia Patients

Journal of the ASEAN Federation of Endocrine Societies, 2014
Objective.  Early diagnosis of congenital adrenal hyperplasia (CAH) and the need for long term treatment are of great concern to the medical community. The aim of this study was to evaluate the effectiveness of glucocorticoid treatment-monitoring based ...
Achmad Zulfa Juniarto, Gerard Noppe, Nani Maharani, Erica van den Akker, Rudy Susanto, Sultana MH Faradz, Frank H. de Jong, Stenvert L.S. Drop   +7 more
doaj  

17-Hydroxyprogesterone Response to Standard Dose Synacthen Stimulation Test in CYP21A2 Heterozygous Carriers and Non-carriers in Symptomatic and Asymptomatic Groups: Meta-analyses [PDF]

J Clin Res Pediatr Endocrinol, 2022
Polat S, Arslan YK.
europepmc   +1 more source

An integrated PK-PD model for cortisol and the 17-hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia. [PDF]

Br J Clin Pharmacol, 2021
Al-Kofahi M, Ahmed MA, Jaber MM, Tran TN, Willis BA, Zimmerman CL, Gonzalez-Bolanos MT, Brundage RC, Sarafoglou K.   +8 more
europepmc   +1 more source

Sexual precocity in a 4 year old boy [PDF]

, 2010
Connell, J.M., Donaldson, M.D.C., Mason, A., McNeill, E., Wallace, A.   +4 more
core   +1 more source

17-Hydroxyprogesterone Measurement [PDF]

, 2020
openaire   +1 more source

Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety

Therapeutics and Clinical Risk Management, 2008
Helen Y How, Baha M SibaiDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, OH USAAbstract: Preterm birth is the leading cause of neonatal mortality and morbidity and long-term disability ...
Helen Y How, Baha M Sibai
doaj  

Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study [PDF]

, 2015

core   +1 more source

Роль дефицита 21-гидроксилазы в генезе врожденной дисфункции коры надпочечников [PDF]

, 2013
Данные о роли дефицита 21 гидроксилазы в генезе врожденной дисфункции коры надпочечниковyesБелгородский государственный ...
Амирасланова, М. М., Мамедова, Н. Ф., Соснова, Е. А.   +2 more
core  

Dexamethasone Therapy of Congenital Adrenal Hyperplasia and the Myth of the “Growth Toxic” Glucocorticoid [PDF]

, 2010
Scott A. Rivkees
core   +1 more source